Health · 1 sources covering this

STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/a04d78a956903b7c70571efe9aa8d6eb94abf252"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials"></iframe>

STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

How 1 sources are covering this

STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

More from Health

Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest

STAT+: UnitedHealthcare’s lactation billing feud, and fake strokes

STAT+: Novo underwhelmed by drug it once fought Pfizer for

STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

More from Health

Health workers at the epicenter of Congo&#8217;s Ebola outbreak labor with little pay or rest

STAT+: UnitedHealthcare’s lactation billing feud, and fake strokes

STAT+: Novo underwhelmed by drug it once fought Pfizer for

STAT+: Pharmalittle: We&#8217;re reading about Lilly and Pfizer obesity drug data, Roche and J&#038;J deals, and more

Reader

Trust & legal

Across the network

Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest

STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more